Tagged with Fact

Eurofarma Eurofarma entered the Peruvian market in 2013 through the acquisition of local player Refasa-Carrión. Rómulo García, the affiliate’s ambitious general manager, discusses the merge and his quest to become a top ten player in the market. Can you give us a brief introduction to Eurofarma; starting from your foundation to…

innovation Induquímica is the only Peruvian pharmaceutical company with the “Marca Peru” emblem, a result of the company’s extremely high quality. General Manager Christian Quintanilla talks about the company’s success, and their unique strategy of relying on their reputation instead of using medical reps to sell their products. In what context…

exports The chairman and general manager of Bottu discuss their flagship product, Doliprane, the potential for export to the rest of Africa, and partnerships with European labs. Bottu is a Moroccan laboratory and is a little over sixty years old. The company experienced a dramatic acceleration in business a few years…

export The CEO of one of Morocco’s largest pharma companies discusses investment in production capacity, and the potential to export products to French and English-speaking Africa.    Can you introduce Pharma 5 and its organization in a few words? The Pharma 5 group, a Moroccan pioneer in generic drug development and…

manufacturing The director general of Cooper Pharma explains how the company has become the leading Moroccan player, why Morocco´s relationship with Africa is one of cooperation not exploitation, and how the country now needs to look towards innovation if it is to compete.   Cooper Pharma celebrated its 80th anniversary in…

doing business The director general of Promopharm explains why Hikma decided to invest in the Moroccan market, why we have to take a long-term perspective when judging the government’s reform agenda and how the main priority will always be responding to patient needs   In 2011 Hikma acquired a 63.9 percent stake…

R&D The CEO of Mega Medical, a Korean medical equipment manufacturer specialized in the ENT area, discusses his firm’s recent expansion into the anti-obesity segment, their strategy for building a global business, and the overall potential of the Korean medical equipment sector.     Korea still relies primarily on imported medical…

Takeda The Japan-based company is changing into a new Takeda. José Manuel Caamaño, general manager of Takeda Mexico, talks about the transformation process the company is going through to become a best-in-class organization. The company’s five-year aim is to be recognized as a best employer in Mexico keeping the values and…

contract manufacturing The chairman of contract manufacturer Korea Pharma discusses the Korean CMO market and incremental innovation.   Where did your idea for starting Korea Pharma come from? I am a pharmacist by training, and graduated from Yeong-nam University’s college of pharmacy. After graduation, I worked for Seoul Pharmaceutical Company for five…

R&D The founder of Eriochem discusses his firm’s ambitious technology based on a competitive IP strategy and its exciting research on a radically new oncology platform. Today, Eriochem is a vertically integrated company producing both APIs and final dosage forms; when you started the company, what was the strategy you followed…

manufacturing The president of Algeria’s union for pharmaceutical operators discusses the state of the local industry and sheds light on the sets of challenges his members (both importers and domestic manufactures) face under the current context. The state expects a radical change in Algeria’s production makeup, with 70 percent of drug needs…

manufacturing The founder of one of Algeria’s pioneer pharmaceutical manufacturers tells his story about how he guided his company up the value chain having originally started off by undertaking the packaging component before moving on to  more complex forms. He also discusses the ‘made in Algeria’ brand and the challenges of sourcing skilled…